GATA - Groupe Athena Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
-0.0199 (-36.25%)
As of 2:04PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.0549
BidN/A x N/A
AskN/A x N/A
Day's Range0.0350 - 0.0520
52 Week Range0.0100 - 0.0900
Avg. Volume730,127
Market Cap1.65M
Beta (3Y Monthly)1.92
PE Ratio (TTM)0.36
EPS (TTM)0.0980
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Groupe Athena, Inc. Posts 1st Quarter Results

    Mumbai, India, Nov. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Groupe Athena, Inc. (Pink sheets GATA) announced today  revenues of $10,211,529 for the period ending September 30, 2018. The Indian pharmaceutical industry is increasingly focusing on exports to the United States and GATA is well positioned to help them get their products approved by the FDA for sales in the US. All of these are potential clients and the Company believes it has an advantage over competitors due to the facilities based in India, and their ability to deliver quick feedback to clients that could result in expedited order generation.

  • We're sorry this is all we were able to find about this topic.